C9ORF72 (Q96LT7) variants and mutations
C9ORF72 (also known as Q96LT7) is a human protein-coding gene encoding a guanine nucleotide exchange factor protein. It participates in endolysosomal trafficking, autophagy, and immune regulation through complexes with SMCR8 and WDR41. A large GGGGCC repeat expansion causes the most common inherited form of amyotrophic lateral sclerosis and frontotemporal dementia. This analysis covers 668 C9ORF72 variants and mutations. Of these, 75% have computational variant effect predictions. Disease context includes amyotrophic lateral sclerosis, frontotemporal dementia and/or amyotrophic lateral sclerosis 1, and frontotemporal dementia with motor neuron disease. Example C9ORF72 variants include S2A, S2L, and S2W.
Variant analysis overview
- Gene: C9ORF72
- Protein: Q96LT7
- UniProt accession: Q96LT7
- Organism: Homo sapiens
- Variants analyzed: 668
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 572 unspecified-consequence records; 1 stop retained variant; 41 missense variants; 12 frameshift variants; 2 in-frame deletions; 30 synonymous variants; 5 stop-gained variants; 2 in-frame insertions; 1 splice-region variants; 2 substitution
- Prediction scores: 502 variants have prediction scores (75% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: amyotrophic lateral sclerosis, frontotemporal dementia and/or amyotrophic lateral sclerosis 1, frontotemporal dementia with motor neuron disease, Abnormality of the skeletal system, Huntington disease-like syndrome due to C9ORF72 expansions, viral eye infection, obesity disorder, alcohol drinking, ovarian dysfunction, gastrointestinal disease, complication, type 2 diabetes mellitus.
Protein structure and variant hotspots
- Protein features: 3 domains.
- Structural context: 559 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable C9ORF72 variants
Examples include S2A, S2L, S2W, L4F, P6S, P7L, P7S, P8L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2A (p.Ser2Ala), NCI-TCGA TCGA novel, TOPMed rs1819487172, gnomAD rs1819487172, REVEL 0.04, MetaLR 0.30, Variant assessed as somatic; moderate impact.
- S2L (p.Ser2Leu), ESP rs149095486, ExAC rs149095486, TOPMed rs149095486, gnomAD rs149095486, REVEL 0.27, CADD 24.70
- S2W (p.Ser2Trp), ESP rs149095486, ExAC rs149095486, TOPMed rs149095486, gnomAD rs149095486, REVEL 0.29, CADD 28.60
- L4F (p.Leu4Phe), TOPMed rs1160361643, gnomAD rs1160361643, REVEL 0.08, AlphaMissense 0.17
- P6S (p.Pro6Ser), ExAC rs752995172, TOPMed rs752995172, gnomAD rs752995172, REVEL 0.23, CADD 25.60
- P7L (p.Pro7Leu), TOPMed rs933551671, gnomAD rs933551671, REVEL 0.27, CADD 26.30
- P7S (p.Pro7Ser), gnomAD rs1819486494, REVEL 0.31, AlphaMissense 0.59
- P8L (p.Pro8Leu), cosmic curated COSV10469, ESP rs377404268, TOPMed rs377404268
- P8S (p.Pro8Ser), cosmic curated COSV10654
- P10A (p.Pro10Ala), ExAC rs749975238, TOPMed rs749975238, gnomAD rs749975238, REVEL 0.29, AlphaMissense 0.92
- P10S (p.Pro10Ser), ExAC rs749975238, TOPMed rs749975238, gnomAD rs749975238, REVEL 0.23, AlphaMissense 0.98
- A11P (p.Ala11Pro), Ensembl rs1819485878, REVEL 0.39, CADD 25.80
- A11V (p.Ala11Val), rs767044830, NCI-TCGA Cosmic COSV6615, cosmic curated COSV66155, ExAC rs767044830, REVEL 0.29, CADD 24.40, Variant assessed as somatic; moderate impact.
- A13T (p.Ala13Thr), TOPMed rs1819485696, REVEL 0.24, CADD 24.00
- T15A (p.Thr15Ala), Ensembl rs2131545629
- E16G (p.Glu16Gly), gnomAD rs905778011, REVEL 0.19, CADD 24.60
- I17F (p.Ile17Phe), TOPMed rs974933058, gnomAD rs974933058, REVEL 0.14, AlphaMissense 0.21
- S20N (p.Ser20Asn), Ensembl rs1044263907, REVEL 0.10, CADD 15.70
- S20R (p.Ser20Arg), Ensembl rs2131545604
- G21D (p.Gly21Asp), Ensembl rs2131545594
- K22E (p.Lys22Glu), Ensembl rs2131545587, REVEL 0.04, CADD 15.90
- K22T (p.Lys22Thr), TOPMed rs1819485216, REVEL 0.09, CADD 22.30
- P24L (p.Pro24Leu), ESP rs373581954, TOPMed rs373581954
- P24S (p.Pro24Ser), Ensembl rs1171667768, REVEL 0.36, AlphaMissense 0.16
- L26I (p.Leu26Ile), cosmic curated COSV66155
- A27T (p.Ala27Thr), NCI-TCGA Cosmic COSV6615, cosmic curated COSV66154, Variant assessed as somatic; moderate impact.
- A27V (p.Ala27Val), gnomAD rs1476251836, REVEL 0.35, CADD 25.00
- A28T (p.Ala28Thr), Ensembl rs748020371
- T29A (p.Thr29Ala), TOPMed rs1421731133, gnomAD rs1421731133, REVEL 0.28, CADD 23.80
- T29I (p.Thr29Ile), ESP rs140145837, ExAC rs140145837, TOPMed rs140145837, gnomAD rs140145837, REVEL 0.39, CADD 22.20
- T29S (p.Thr29Ser), ESP rs140145837, ExAC rs140145837, TOPMed rs140145837, gnomAD rs140145837, REVEL 0.25, CADD 25.50
- F30Y (p.Phe30Tyr), gnomAD rs1186209274, REVEL 0.22, CADD 24.00
- A31S (p.Ala31Ser), ExAC rs768123891, TOPMed rs768123891, gnomAD rs768123891, REVEL 0.25, CADD 21.60
- Y32C (p.Tyr32Cys), ExAC rs775414064, gnomAD rs775414064, REVEL 0.41, CADD 28.60
- W33* (p.Trp33Ter), gnomAD rs1271940652, CADD 37.00
- L37F (p.Leu37Phe), NCI-TCGA Cosmic COSV6615, cosmic curated COSV66155, Variant assessed as somatic; moderate impact.
- L37R (p.Leu37Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V41G (p.Val41Gly), ExAC rs781240158, gnomAD rs781240158, REVEL 0.62, CADD 27.80
- V41I (p.Val41Ile), ExAC rs745772901, TOPMed rs745772901, gnomAD rs745772901, REVEL 0.21, AlphaMissense 0.92
- R42M (p.Arg42Met), Ensembl rs1554661523
- H43R (p.His43Arg), Ensembl rs1014483798, REVEL 0.42, CADD 25.40
- I44V (p.Ile44Val), TOPMed rs1362314955, gnomAD rs1362314955, REVEL 0.16, AlphaMissense 0.98
- A46D (p.Ala46Asp), Ensembl rs1053249621, REVEL 0.14, CADD 21.50
- A46S (p.Ala46Ser), ExAC rs778062788, gnomAD rs778062788, REVEL 0.09, AlphaMissense 0.99
- A46T (p.Ala46Thr), ExAC rs778062788, gnomAD rs778062788, REVEL 0.07, CADD 19.50
- P47A (p.Pro47Ala), 1000Genomes rs181815263, ESP rs181815263, ExAC rs181815263, TOPMed rs181815263, REVEL 0.24, AlphaMissense 0.32
- P47Q (p.Pro47Gln), Ensembl rs1554661513
- P47S (p.Pro47Ser), cosmic curated COSV10118, 1000Genomes rs181815263, ESP rs181815263, ExAC rs181815263, REVEL 0.28, AlphaMissense 0.19
- P47T (p.Pro47Thr), 1000Genomes rs181815263, ESP rs181815263, ExAC rs181815263, TOPMed rs181815263
- K48T (p.Lys48Thr), gnomAD rs1370119959, REVEL 0.20, CADD 24.00
- T49R (p.Thr49Arg), 1000Genomes rs201250307, ESP rs201250307, ExAC rs201250307, TOPMed rs201250307, REVEL 0.04, CADD 21.40
- E50A (p.Glu50Ala), TOPMed rs1414695944, gnomAD rs1414695944, REVEL 0.07, CADD 23.90
- E50K (p.Glu50Lys), ExAC rs766734628, gnomAD rs766734628, REVEL 0.03, CADD 21.20
- Q51* (p.Gln51Ter), gnomAD rs1169929002, CADD 37.00
- Q51P (p.Gln51Pro), ExAC rs761388023, gnomAD rs761388023
- Q51R (p.Gln51Arg), ExAC rs761388023, gnomAD rs761388023, REVEL 0.05, CADD 18.50
- V52I (p.Val52Ile), cosmic curated COSV10822, ESP rs144163719, ExAC rs144163719, TOPMed rs144163719, REVEL 0.02, CADD 3.15
- V52L (p.Val52Leu), ESP rs144163719, ExAC rs144163719, TOPMed rs144163719, gnomAD rs144163719, REVEL 0.01, CADD 2.43
- L53F (p.Leu53Phe), gnomAD rs1189869941, REVEL 0.10, CADD 19.60
- L54F (p.Leu54Phe), 1000Genomes rs199871012, REVEL 0.23, CADD 23.80
- D56E (p.Asp56Glu), cosmic curated COSV10118
- G57A (p.Gly57Ala), NCI-TCGA Cosmic COSV6615, cosmic curated COSV66154, Ensembl rs1819481651, REVEL 0.17, CADD 23.40, Variant assessed as somatic; moderate impact.
- T60I (p.Thr60Ile), TOPMed rs1405515469, gnomAD rs1405515469, REVEL 0.14, CADD 22.50
- F61S (p.Phe61Ser), TOPMed rs1324943336, gnomAD rs1324943336, REVEL 0.70, CADD 28.30
- T66A (p.Thr66Ala), ESP rs373709108, ExAC rs373709108, TOPMed rs373709108, gnomAD rs373709108, REVEL 0.56, AlphaMissense 0.99
- T66S (p.Thr66Ser), ESP rs373709108, ExAC rs373709108, TOPMed rs373709108, gnomAD rs373709108, REVEL 0.37, AlphaMissense 0.99
- L67I (p.Leu67Ile), cosmic curated COSV10118
- N68H (p.Asn68His), gnomAD rs1819480894, REVEL 0.29, CADD 25.90
- G69E (p.Gly69Glu), 1000Genomes rs575487786, TOPMed rs575487786, gnomAD rs575487786, REVEL 0.41, CADD 25.70
- L72V (p.Leu72Val), cosmic curated COSV10118
- R73* (p.Arg73Ter), TOPMed rs1274729596, gnomAD rs1274729596, CADD 38.00
- R73P (p.Arg73Pro), Ensembl rs1819480368, Uncertain significance
- R73Q (p.Arg73Gln), rs1819480368, ClinGen CA373140774, NCI-TCGA Cosmic COSV6615, cosmic curated COSV66154, REVEL 0.27, CADD 27.00, Uncertain significance, Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
- N74Y (p.Asn74Tyr), Ensembl rs1819480304
- E76D (p.Glu76Asp), NCI-TCGA Cosmic COSV6615, cosmic curated COSV66154, TOPMed rs1819480050, REVEL 0.14, AlphaMissense 0.31, Variant assessed as somatic; moderate impact.
- E76G (p.Glu76Gly), rs906448560, NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, TOPMed rs906448560, REVEL 0.24, CADD 24.30, Variant assessed as somatic; moderate impact.
- E76K (p.Glu76Lys), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- S77C (p.Ser77Cys), TOPMed rs1357313941
- S77G (p.Ser77Gly), TOPMed rs1357313941, REVEL 0.04, AlphaMissense 0.44
- S77R (p.Ser77Arg), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- S77T (p.Ser77Thr), gnomAD rs1231777887, REVEL 0.05, AlphaMissense 0.31
- A79G (p.Ala79Gly), ExAC rs776723269, TOPMed rs776723269, gnomAD rs776723269, REVEL 0.32, CADD 26.40
- I80V (p.Ile80Val), TOPMed rs1443022155, gnomAD rs1443022155, REVEL 0.05, CADD 17.30
- D81G (p.Asp81Gly), ExAC rs770707789, gnomAD rs770707789, REVEL 0.51, AlphaMissense 0.61
- V82I (p.Val82Ile), TOPMed rs1230155966
- K83Q (p.Lys83Gln), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- V86F (p.Val86Phe), TOPMed rs1023923990, gnomAD rs1023923990, REVEL 0.34, CADD 25.20
- V86I (p.Val86Ile), TOPMed rs1023923990, gnomAD rs1023923990, REVEL 0.18, CADD 23.10
- L87F (p.Leu87Phe), ExAC rs748399586, gnomAD rs748399586
- L87V (p.Leu87Val), ExAC rs565771464, TOPMed rs565771464, gnomAD rs565771464, REVEL 0.27, AlphaMissense 0.96
- S88C (p.Ser88Cys), ExAC rs779057588, gnomAD rs779057588
- E89* (p.Glu89Ter), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; high impact.
- E89G (p.Glu89Gly), ExAC rs755346261, gnomAD rs755346261
- E89K (p.Glu89Lys), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, REVEL 0.21, CADD 26.00, Variant assessed as somatic; moderate impact.
- G91R (p.Gly91Arg), NCI-TCGA TCGA novel, REVEL 0.14, CADD 23.20, Variant assessed as somatic; moderate impact.
- V95A (p.Val95Ala), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- V95I (p.Val95Ile), gnomAD rs547548706, REVEL 0.16, CADD 23.10
- S96L (p.Ser96Leu), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- I98V (p.Ile98Val), gnomAD rs1208368236, REVEL 0.18, CADD 19.40
- F99S (p.Phe99Ser), Ensembl rs1819477994
- D100N (p.Asp100Asn), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- W103C (p.Trp103Cys), ESP rs369687342, TOPMed rs369687342
- N104K (p.Asn104Lys), gnomAD rs1280803382, REVEL 0.14, CADD 15.50
- N104S (p.Asn104Ser), TOPMed rs1315702993, gnomAD rs1315702993, REVEL 0.06, CADD 19.50
- R107C (p.Arg107Cys), cosmic curated COSV66154, gnomAD rs1819477480, REVEL 0.20, CADD 23.60
- R107H (p.Arg107His), cosmic curated COSV66154, ESP rs145645318, ExAC rs145645318, TOPMed rs145645318, REVEL 0.17, CADD 23.90
- R107L (p.Arg107Leu), cosmic curated COSV66154
- R107P (p.Arg107Pro), ESP rs145645318, ExAC rs145645318, TOPMed rs145645318, gnomAD rs145645318, REVEL 0.23, CADD 23.00
- S108I (p.Ser108Ile), cosmic curated COSV66155, REVEL 0.17, CADD 22.30
- S108N (p.Ser108Asn), cosmic curated COSV66155, REVEL 0.09, CADD 17.70
- T109A (p.Thr109Ala), TOPMed rs1306246315, gnomAD rs1306246315, REVEL 0.36, CADD 23.40
- T109I (p.Thr109Ile), TOPMed rs1362925313
- Y110* (p.Tyr110Ter), ExAC rs781421755, CADD 33.00
- Y110C (p.Tyr110Cys), rs1375695528, ClinGen CA373140524, ClinVar RCV001168603, gnomAD rs1375695528, REVEL 0.11, CADD 22.60, Uncertain significance, Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
- G111R (p.Gly111Arg), NCI-TCGA Cosmic COSV6615, cosmic curated COSV66154, Variant assessed as somatic; moderate impact.
- L112P (p.Leu112Pro), ExAC rs776286891, gnomAD rs776286891, REVEL 0.71, CADD 27.10
- S113L (p.Ser113Leu), gnomAD rs922724756, REVEL 0.59, CADD 25.10
- I114V (p.Ile114Val), ExAC rs373008422, TOPMed rs373008422, gnomAD rs373008422, REVEL 0.03, CADD 19.40
- I115M (p.Ile115Met), ExAC rs760497690, TOPMed rs760497690, gnomAD rs760497690, REVEL 0.22, AlphaMissense 0.37
- L116F (p.Leu116Phe), cosmic curated COSV66154
- P117S (p.Pro117Ser), Ensembl rs1169192790
- P117L (p.Pro117Leu), rs776286891, []
- T119A (p.Thr119Ala), TOPMed rs1407836422, gnomAD rs1407836422, REVEL 0.02, AlphaMissense 0.32
- E120D (p.Glu120Asp), TOPMed rs1327923124, gnomAD rs1327923124, REVEL 0.19, CADD 14.40
- E120V (p.Glu120Val), Ensembl rs1819475858
- L121F (p.Leu121Phe), TOPMed rs1363703997, gnomAD rs1363703997, REVEL 0.37, CADD 26.40
- S122C (p.Ser122Cys), ExAC rs773159639, gnomAD rs773159639, REVEL 0.17, CADD 23.40
- S122R (p.Ser122Arg), ExAC rs773159639, gnomAD rs773159639, REVEL 0.15, CADD 22.20
- Y124F (p.Tyr124Phe), TOPMed rs1450470785, REVEL 0.46, CADD 24.10
- L125F (p.Leu125Phe), ESP rs372541138, TOPMed rs372541138, gnomAD rs372541138, REVEL 0.46, CADD 26.30
- L125V (p.Leu125Val), ESP rs372541138, TOPMed rs372541138, gnomAD rs372541138, REVEL 0.41, CADD 23.90
- P126T (p.Pro126Thr), cosmic curated COSV66154
- H128Y (p.His128Tyr), gnomAD rs1485151227
- R129G (p.Arg129Gly), Ensembl rs2131545147
- V130A (p.Val130Ala), gnomAD rs1484801234, REVEL 0.23, CADD 22.80
- D133N (p.Asp133Asn), ExAC rs749708068, gnomAD rs749708068, REVEL 0.11, CADD 22.90
- R134S (p.Arg134Ser), TOPMed rs1340645714
- H137L (p.His137Leu), ExAC rs753158467, gnomAD rs753158467, REVEL 0.31, CADD 22.50
- H137P (p.His137Pro), ExAC rs753158467, gnomAD rs753158467, REVEL 0.42, CADD 23.90
- H137R (p.His137Arg), ExAC rs753158467, gnomAD rs753158467, REVEL 0.23, CADD 22.40
- I138M (p.Ile138Met), Ensembl rs1819473964, REVEL 0.15, AlphaMissense 0.10
- I138T (p.Ile138Thr), gnomAD rs1295400337, REVEL 0.11, CADD 23.00
- R140L (p.Arg140Leu), ExAC rs781692000, gnomAD rs781692000, REVEL 0.36, CADD 24.10
- R140Q (p.Arg140Gln), cosmic curated COSV66154, ExAC rs781692000, gnomAD rs781692000, REVEL 0.25, CADD 24.40
- R140W (p.Arg140Trp), cosmic curated COSV10593, ExAC rs756687033, TOPMed rs756687033, gnomAD rs756687033, REVEL 0.28, CADD 28.20
- G142* (p.Gly142Ter), cosmic curated COSV10532
- G142E (p.Gly142Glu), 1000Genomes rs558489073, gnomAD rs558489073, REVEL 0.44, CADD 26.40
- G142V (p.Gly142Val), 1000Genomes rs558489073, gnomAD rs558489073, REVEL 0.41, CADD 24.20
- R143K (p.Arg143Lys), Ensembl rs1819473436, REVEL 0.32, CADD 26.50
- I144T (p.Ile144Thr), Ensembl rs1819473344
- W145G (p.Trp145Gly), gnomAD rs1455815295, REVEL 0.22, AlphaMissense 0.99
- W145R (p.Trp145Arg), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- M146L (p.Met146Leu), gnomAD rs1273640725, REVEL 0.25, CADD 22.30
- H147R (p.His147Arg), ExAC rs757995593, gnomAD rs757995593
- H147Y (p.His147Tyr), gnomAD rs1390136699, REVEL 0.27, CADD 22.20
- K148N (p.Lys148Asn), gnomAD rs1474620143, REVEL 0.25, CADD 33.00
- R150S (p.Arg150Ser), TOPMed rs1359333719, REVEL 0.21, CADD 18.10
- Q151P (p.Gln151Pro), ExAC rs768913769, gnomAD rs768913769, REVEL 0.17, AlphaMissense 0.61
- Q151R (p.Gln151Arg), rs781692000, []
- E152* (p.Glu152Ter), TOPMed rs1819450324, CADD 44.00
- E152K (p.Glu152Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N153K (p.Asn153Lys), TOPMed rs1206413759, gnomAD rs1206413759, REVEL 0.01, CADD 17.70
- N153S (p.Asn153Ser), gnomAD rs1424359653, REVEL 0.08, CADD 15.30
- Q155* (p.Gln155Ter), gnomAD rs1451144396, CADD 46.00
- Q155K (p.Gln155Lys), cosmic curated COSV10118
- K156N (p.Lys156Asn), rs770077991, ExAC rs770077991, TOPMed rs770077991, gnomAD rs770077991, REVEL 0.08, CADD 22.70, Likely benign, C9orf72-related disorder
- I158T (p.Ile158Thr), gnomAD rs1468916949, REVEL 0.10, CADD 22.00
- G161R (p.Gly161Arg), ExAC rs781558367, gnomAD rs781558367, REVEL 0.25, CADD 23.50
- E163G (p.Glu163Gly), gnomAD rs1819449241, REVEL 0.14, CADD 24.70
- R164K (p.Arg164Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M165T (p.Met165Thr), Ensembl rs200598638, REVEL 0.20, CADD 22.90
- M165V (p.Met165Val), ESP rs370135790, ExAC rs370135790, TOPMed rs370135790, gnomAD rs370135790, REVEL 0.15, CADD 22.70
- E166G (p.Glu166Gly), TOPMed rs965154707, gnomAD rs965154707, REVEL 0.18, CADD 26.20
- E166K (p.Glu166Lys), ESP rs368117087, ExAC rs368117087, TOPMed rs368117087, gnomAD rs368117087, REVEL 0.20, CADD 24.10
- E166V (p.Glu166Val), TOPMed rs965154707, gnomAD rs965154707, REVEL 0.15, CADD 29.50
- D167H (p.Asp167His), ExAC rs754495907, gnomAD rs754495907, REVEL 0.18, CADD 24.10
- Q168* (p.Gln168Ter), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, CADD 52.00, Variant assessed as somatic; high impact.
- Q168H (p.Gln168His), TOPMed rs1303312037, gnomAD rs1303312037, REVEL 0.24, CADD 35.00
- Q168R (p.Gln168Arg), TOPMed rs1017594063, REVEL 0.24, CADD 31.00
- G169R (p.Gly169Arg), ExAC rs763962885, gnomAD rs763962885, REVEL 0.35, CADD 27.60
Public C9ORF72 analysis runs
- C9ORF72 analysis run — C9orf72 (668 variants) — completed 2026-08-19